Ebit Changement Date
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
ALKERMES USD -65.93M 17.65M 2026-06
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 4.61B 777M 2026-06
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 116M 2025-12
Cytokinetics USD -179.17M 2.05M 2026-06
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -101.31M 98.97M 2026-06
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
MannKind USD -68.23M 8.76M 2026-06
Merck EUR 1.1B 51M 2026-06
Moderna USD -815M 573M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Pfizer USD -180M 5.16B 2026-06
Sanofi EUR 1.12B 811M 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06